Results 141 to 150 of about 485,652 (302)

Trends in drug–drug interaction prevalence and longitudinal associations with health outcomes in the older community‐dwelling population: Findings from The Irish LongituDinal study on Ageing

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims We estimate trends in severe drug–drug interaction (DDI) prevalence and examine longitudinal associations between DDI exposure and health outcomes (emergency department [ED] visits, quality‐of‐life [QoL] and functional decline) over approximately 10‐years in the older community‐dwelling population in Ireland.
John E. Hughes   +2 more
wiley   +1 more source

Economic evaluation of a robotic chemotherapy compounding system and its service expansion to network hospital in Thailand. [PDF]

open access: yesBMC Health Serv Res
Lukanawonakul A   +5 more
europepmc   +1 more source

Therapeutic reasoning in case reports: Insights into current reporting and learning opportunities

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims While case reports can help to train diagnostic reasoning, will they improve therapeutic reasoning as well? Prescribing the right medication is difficult and prone to error, which can lead to patient harm. Therefore, good therapeutic reasoning skills are essential.
Mariëlle G. Hartjes   +5 more
wiley   +1 more source

A quantitative assessment of current practice in diabetes and hypertension services in pharmacies in urban Nepal. [PDF]

open access: yesPLoS One
Shrestha G   +8 more
europepmc   +1 more source

Under‐Interpretation of Neuroimaging Data in Insanity Assessment: A Hidden Risk

open access: yesBehavioral Sciences &the Law, EarlyView.
ABSTRACT Neuroimaging data can provide valuable insights into insanity evaluations, but the debate over its use for legal purposes is far from resolved. While much attention has been given to the risks of over‐interpretation, potential errors stemming from under‐interpretation received less scrutiny. In this paper, we aim to showcase how this error may
Camilla Frangi   +5 more
wiley   +1 more source

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

open access: yesCancer Communications, EarlyView.
Abstract Background The combined use of anti‐programmed cell death protein 1 (PD‐1)/anti‐cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4) checkpoint inhibitors has been effective in various cancer types. The Southwest Oncology Group (SWOG) Dual Anti‐CTLA‐4 and Anti‐PD‐1 Blockade in Rare Tumors (DART) S1609 study investigated ipilimumab and ...
Young Kwang Chae   +16 more
wiley   +1 more source

Are Decentralized Pharmacy Services the Preferred Model of Pharmacy Service Delivery within a Hospital?

open access: yesThe Canadian Journal of Hospital Pharmacy, 2015
Anna Maruyama   +9 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy